Kamada (KMDA) Share-based Compensation (QoQ) (2013 - 2026)
Kamada (KMDA) Share-based Compensation (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Kamada | 464.34 Mn | 434.87 Mn | 22.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.00% |
| Mar 31, 2026 | 127.92% |
| Dec 31, 2025 | 200.00% |
| Sep 30, 2025 | 23.16% |
| Jun 30, 2025 | -45.71% |
| Mar 31, 2025 | 24.11% |
| Dec 31, 2024 | -37.05% |
| Sep 30, 2024 | -4.68% |
| Jun 30, 2024 | -2.49% |
| Mar 31, 2024 | -90.96% |
| Dec 31, 2023 | 754.49% |
| Sep 30, 2023 | 45.79% |
| Jun 30, 2023 | 51,466.27% |
| Mar 31, 2023 | -98.34% |
| Dec 31, 2022 | 6,730.60% |
| Sep 30, 2022 | -99.90% |
| Jun 30, 2022 | 94.82% |
| Mar 31, 2022 | 153.95% |
| Dec 31, 2021 | -43.28% |
| Sep 30, 2021 | -13.55% |